Sera Prognostics, Inc. - Class A Common Stock (SERA)
3.9300
-0.2100 (-5.07%)
Sera Prognostics Inc is a biotechnology company focused on advancing maternal and fetal health through innovative diagnostic solutions
The company primarily develops predictive tests that aim to assess the risk of pregnancy complications, enabling healthcare providers to offer personalized care and interventions for expectant mothers and their babies. By harnessing advanced biomarker analysis and machine learning technologies, Sera Prognostics seeks to improve pregnancy outcomes and reduce healthcare costs associated with managing high-risk pregnancies. Their commitment to research and collaboration with healthcare professionals highlights their dedication to enhancing the overall well-being of mothers and infants.
The Benzinga Stock Whisper Index highlights five stocks seeing increased interest from readers during the past week and a look at the reasons why and what's next.
Companies Reporting Before The Bell • UP Fintech Holding (NASDAQ:TIGR) is expected to report quarterly earnings at $0.07 per share on revenue of $207.00 million.
U.S. stocks traded mixed toward the end of trading on Wednesday. The Dow traded up 0.05% to 36,143.40 while the NASDAQ fell 0.06% to 14,221.51. The S&P 500 also fell, dropping, 0.05% to 4,564.73.
U.S. stocks traded mostly flat midway through trading, with the S&P 500 turning lower on Wednesday. The Dow traded up 0.01% to 36,126.75 while the NASDAQ rose 0.03% to 14,233.77. The S&P 500 also fell, dropping, 0.05% to 4,565.09.
